$BDRL
BLONDER TONGUE LABORATORIES INC

2014 Q2 Form 10-Q Financial Statement

#000114420414049699 Filed on August 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $8.828M $7.146M
YoY Change 23.54% -8.42%
Cost Of Revenue $5.353M $4.694M
YoY Change 14.04% -9.73%
Gross Profit $3.475M $2.452M
YoY Change 41.72% -5.8%
Gross Profit Margin 39.36% 34.31%
Selling, General & Admin $2.133M $2.199M
YoY Change -3.0% 1.24%
% of Gross Profit 61.38% 89.68%
Research & Development $929.0K $836.0K
YoY Change 11.12% -10.11%
% of Gross Profit 26.73% 34.09%
Depreciation & Amortization $350.0K $320.0K
YoY Change 9.38% -15.79%
% of Gross Profit 10.07% 13.05%
Operating Expenses $3.062M $3.035M
YoY Change 0.89% -2.16%
Operating Profit $413.0K -$583.0K
YoY Change -170.84% 16.83%
Interest Expense $66.00K $77.00K
YoY Change -14.29% -196.25%
% of Operating Profit 15.98%
Other Income/Expense, Net -$77.00K
YoY Change -8.33%
Pretax Income $347.0K -$660.0K
YoY Change -152.58% 13.21%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $347.0K -$660.0K
YoY Change -152.58% 13.21%
Net Earnings / Revenue 3.93% -9.24%
Basic Earnings Per Share
Diluted Earnings Per Share $0.06 -$0.11
COMMON SHARES
Basic Shares Outstanding 6.216M shares 6.216M shares
Diluted Shares Outstanding 6.240M shares 6.216M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00K $170.0K
YoY Change -70.59% -19.05%
Cash & Equivalents $49.00K $173.0K
Short-Term Investments
Other Short-Term Assets $980.0K $920.0K
YoY Change 6.52% -28.68%
Inventory $8.437M $10.50M
Prepaid Expenses
Receivables $4.517M $2.733M
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.99M $14.32M
YoY Change -2.34% -11.15%
LONG-TERM ASSETS
Property, Plant & Equipment $3.975M $3.853M
YoY Change 3.17% -11.43%
Goodwill $493.0K $493.0K
YoY Change 0.0%
Intangibles $730.0K $580.0K
YoY Change 25.86%
Long-Term Investments
YoY Change
Other Assets $143.0K $177.0K
YoY Change -19.21% -97.66%
Total Long-Term Assets $9.239M $9.836M
YoY Change -6.07% -36.46%
TOTAL ASSETS
Total Short-Term Assets $13.99M $14.32M
Total Long-Term Assets $9.239M $9.836M
Total Assets $23.23M $24.16M
YoY Change -3.86% -23.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.320M $1.320M
YoY Change 75.76% -43.35%
Accrued Expenses $650.0K $1.270M
YoY Change -48.82% -19.62%
Deferred Revenue
YoY Change
Short-Term Debt $1.790M $1.590M
YoY Change 12.58% -58.7%
Long-Term Debt Due $3.970M $277.0K
YoY Change 1333.21% 2.59%
Total Short-Term Liabilities $8.747M $4.484M
YoY Change 95.07% -44.5%
LONG-TERM LIABILITIES
Long-Term Debt $76.00K $4.025M
YoY Change -98.11% -5.96%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $76.00K $4.025M
YoY Change -98.11% -5.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.747M $4.484M
Total Long-Term Liabilities $76.00K $4.025M
Total Liabilities $8.823M $8.509M
YoY Change 3.69% -31.16%
SHAREHOLDERS EQUITY
Retained Earnings -$4.008M -$1.514M
YoY Change 164.73%
Common Stock $26.32M $26.06M
YoY Change 1.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.308M $7.308M
YoY Change 0.0%
Treasury Stock Shares 2.248M shares 2.248M shares
Shareholders Equity $14.34M $15.62M
YoY Change
Total Liabilities & Shareholders Equity $23.23M $24.16M
YoY Change -3.86% -23.55%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $347.0K -$660.0K
YoY Change -152.58% 13.21%
Depreciation, Depletion And Amortization $350.0K $320.0K
YoY Change 9.38% -15.79%
Cash From Operating Activities -$10.00K $510.0K
YoY Change -101.96% 750.0%
INVESTING ACTIVITIES
Capital Expenditures $550.0K $190.0K
YoY Change 189.47% -5.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$550.0K -$190.0K
YoY Change 189.47% -5.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 490.0K -220.0K
YoY Change -322.73% -540.0%
NET CHANGE
Cash From Operating Activities -10.00K 510.0K
Cash From Investing Activities -550.0K -190.0K
Cash From Financing Activities 490.0K -220.0K
Net Change In Cash -70.00K 100.0K
YoY Change -170.0% -211.11%
FREE CASH FLOW
Cash From Operating Activities -$10.00K $510.0K
Capital Expenditures $550.0K $190.0K
Free Cash Flow -$560.0K $320.0K
YoY Change -275.0% -328.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
8437000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
8975000 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
569000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
458000 USD
CY2014Q2 us-gaap Prepaid Pension Costs
PrepaidPensionCosts
415000 USD
CY2013Q4 us-gaap Prepaid Pension Costs
PrepaidPensionCosts
415000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
13987000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
13156000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3241000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4517000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6216000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6216000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6216000 shares
CY2014Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
1809000 USD
CY2013Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2115000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3975000 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
730000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2089000 USD
CY2014Q2 us-gaap Goodwill
Goodwill
493000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000 USD
CY2014Q2 us-gaap Assets
Assets
23226000 USD
CY2013Q4 us-gaap Assets
Assets
22641000 USD
CY2013Q4 us-gaap Line Of Credit
LineOfCredit
1275000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
270000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1493000 USD
CY2013Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
446000 USD
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
24000 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
150000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8747000 USD
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
76000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
63000 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26316000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4008000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-668000 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
7308000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
14340000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23226000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22641000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
166000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
196000 USD
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2248000 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2248000 shares
CY2014Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
1718000 USD
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2015-02-01
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1458000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1828000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1022000 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1967000 shares
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4580000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5351000 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3567000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2815000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4557000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5394000 USD
CY2014Q2 us-gaap Inventory Gross
InventoryGross
12704000 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
13560000 USD
CY2014Q2 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4267000 USD
CY2013Q4 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4585000 USD
CY2014Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2458000 USD
CY2013Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2470000 USD
CY2013 bdr Percentage Of Fifo Inventory Non Current For Finished Goods
PercentageOfFifoInventoryNonCurrentForFinishedGoods
0.6 pure
CY2014Q2 bdr Percentage Of Fifo Inventory Non Current For Finished Goods
PercentageOfFifoInventoryNonCurrentForFinishedGoods
0.6 pure
CY2014Q2 us-gaap Inventory Related Text
InventoryRelatedText
Inventories are stated at the lower of cost, determined by the first-in, first-out (FIFO) method, or market
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13865000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
14406000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7146000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8828000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
8925000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9174000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4694000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5353000 USD
us-gaap Gross Profit
GrossProfit
4940000 USD
us-gaap Gross Profit
GrossProfit
5232000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
2452000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
3475000 USD
us-gaap Selling Expense
SellingExpense
1711000 USD
us-gaap Selling Expense
SellingExpense
1693000 USD
CY2013Q2 us-gaap Selling Expense
SellingExpense
885000 USD
CY2014Q2 us-gaap Selling Expense
SellingExpense
881000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2534000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2470000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1314000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1252000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1691000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1769000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
836000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
929000 USD
us-gaap Operating Expenses
OperatingExpenses
5936000 USD
us-gaap Operating Expenses
OperatingExpenses
5932000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
3035000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
3062000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-583000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
413000 USD
us-gaap Interest Expense
InterestExpense
146000 USD
us-gaap Interest Expense
InterestExpense
114000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
77000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
66000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-996000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1142000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-814000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-660000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
347000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-1142000 USD
us-gaap Net Income Loss
NetIncomeLoss
-814000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-660000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
347000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2008 us-gaap Line Of Credit Facility Increase Decrease Other Net
LineOfCreditFacilityIncreaseDecreaseOtherNet
9350000 USD
CY2008Q3 us-gaap Line Of Credit
LineOfCredit
8000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
136000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
126000 USD
us-gaap Depreciation
Depreciation
233000 USD
us-gaap Depreciation
Depreciation
220000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
432000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
498000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
69000 USD
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
0 USD
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
30000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-728000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1246000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1027000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-775000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
193000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
111000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-48000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-346000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
879000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
923000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
382000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
77000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
485000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
333000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
309000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-410000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-794000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-655000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
516000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
138000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
122000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-793000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
394000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-280000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
453000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173000 USD
us-gaap Interest Paid
InterestPaid
139000 USD
us-gaap Interest Paid
InterestPaid
122000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
BLONDER TONGUE LABORATORIES INC
dei Entity Central Index Key
EntityCentralIndexKey
0001000683
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
BDR
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6216372 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6240000 shares

Files In Submission

Name View Source Status
0001144204-14-049699-index-headers.html Edgar Link pending
0001144204-14-049699-index.html Edgar Link pending
0001144204-14-049699.txt Edgar Link pending
0001144204-14-049699-xbrl.zip Edgar Link pending
bdr-20140630.xml Edgar Link completed
bdr-20140630.xsd Edgar Link pending
bdr-20140630_cal.xml Edgar Link unprocessable
bdr-20140630_def.xml Edgar Link unprocessable
bdr-20140630_lab.xml Edgar Link unprocessable
bdr-20140630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v385938_10q.htm Edgar Link pending
v385938_ex10-4.htm Edgar Link pending
v385938_ex10-5.htm Edgar Link pending
v385938_ex31-1.htm Edgar Link pending
v385938_ex31-2.htm Edgar Link pending
v385938_ex32-1.htm Edgar Link pending